GRTX — Galera Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement
Brief: Galera Therapeutics Receives Letter From Nasdaq Indicating That Co Has Not Regained Compliance With Listing Rules
Brief: Yair Schneid Reports 13.073% Passive Stake In Galera Therapeutics - SEC Filing
Brief: Galera Announces Receipt Of Type A Meeting Minutes And Strategic Update
Brief: Galera Therapeutics Inc - Received Notices Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Galera Schedules Type A Meeting With FDA To Discuss Next Steps For Inflammation Disease Drug
Galera Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Galera Therapeutics Q2 EPS USD -0.48
U.S. STOCKS ON THE MOVE-Air Transport Services Group, Dillard's, Precigen
Galera Therapeutics hits record low after FDA declines to approve inflammation drug
U.S. STOCKS ON THE MOVE-Capri Holdings, Amyris, gold miners
U.S. STOCKS ON THE MOVE-YETI Holdings, Catalyst Pharma, ZimVie
U.S. STOCKS ON THE MOVE-Capri, Digital World, Lyft
Galera Therapeutics sinks after FDA declines to approve inflammation drug
U.S. RESEARCH ROUNDUP-Penn Entertainment, Roblox, Sonendo
Galera shares tank after US FDA declines to approve inflammation disease drug